1. Xiang, Jun, Wen, Fang, Zhang, Lingyun, Zhou, Yu. 2017. FOXD3 inhibits SCN2A gene transcription in intractable epilepsy cell models. In Experimental neurology, 302, 14-21. doi:10.1016/j.expneurol.2017.12.012. https://pubmed.ncbi.nlm.nih.gov/29288635/
2. Yang, Xiufang, Du, Huilan, Bian, Wenhui, Li, Qingxue, Sun, Hairu. 2021. FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression. In Oncology reports, 45, . doi:10.3892/or.2021.8013. https://pubmed.ncbi.nlm.nih.gov/33760158/
3. Liu, Ruimin, Sun, Yan, Chen, Shuai, Hong, Yun, Lu, Zhongxian. 2022. FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis. In The FEBS journal, 289, 4536-4548. doi:10.1111/febs.16403. https://pubmed.ncbi.nlm.nih.gov/35178865/
4. Luo, Gui-Fang, Chen, Chang-Ye, Wang, Juan, Li, Yu-Kun, Li, Yan. 2019. FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer. In Cancer cell international, 19, 44. doi:10.1186/s12935-019-0755-8. https://pubmed.ncbi.nlm.nih.gov/30858761/
5. Spritz, Richard A, Andersen, Genevieve H L. . Genetics of Vitiligo. In Dermatologic clinics, 35, 245-255. doi:10.1016/j.det.2016.11.013. https://pubmed.ncbi.nlm.nih.gov/28317533/
6. Kubic, Jennifer D, Little, Elizabeth C, Kaiser, Rebecca S, Young, Kacey P, Lang, Deborah. 2015. FOXD3 Promotes PAX3 Expression in Melanoma Cells. In Journal of cellular biochemistry, 117, 533-41. doi:10.1002/jcb.25306. https://pubmed.ncbi.nlm.nih.gov/26252164/
7. Li, Zhang, Li, Ming, Xia, Pengcheng, Wang, Lili, Lu, Zhiming. 2021. LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis. In Cancer management and research, 13, 9037-9048. doi:10.2147/CMAR.S324920. https://pubmed.ncbi.nlm.nih.gov/34916848/
智鼠故事 
